| RS2523727054 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS2523728931 |
ABCA4
|
Health Risk |
Pathogenic |
Stargardt disease, Stargardt disease |
| RS2523729105 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS2523729277 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2523729282 |
ABCA4
|
Health Risk |
Likely pathogenic |
Severe early-childhood-onset retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS2523729567 |
CAMTA1
|
Health Risk |
Pathogenic |
Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Cerebellar dysfunction with variable cognitive and behavioral abnormalities |
| RS2523729722 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523730625 |
CAMTA1
|
Health Risk |
Pathogenic |
Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Cerebellar dysfunction with variable cognitive and behavioral abnormalities |
| RS2523730908 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2523730965 |
SASS6
|
Health Risk |
Likely pathogenic |
Microcephaly 14, primary |
| RS2523732620 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS2523732681 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS2523732838 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2523733624 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2523734375 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2523734498 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2523734922 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523734931 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523734936 |
ALG6
|
Health Risk |
Pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523735493 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2523736429 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2523737120 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS2523737446 |
ALG6
|
Health Risk |
Pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523737978 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523738513 |
ATP13A2
|
Health Risk |
Pathogenic |
Autosomal recessive spastic paraplegia type 78, Autosomal recessive spastic paraplegia type 78 |
| RS2523738693 |
CAMTA1
|
Health Risk |
Pathogenic |
Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Cerebellar dysfunction with variable cognitive and behavioral abnormalities |
| RS2523741447 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS2523744619 |
MUTYH
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS2523745739 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS2523746202 |
GLMN
|
Health Risk |
Likely pathogenic |
Glomuvenous malformation, Glomuvenous malformation |
| RS2523747340 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS2523747807 |
ALG6
|
Health Risk |
Pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523747951 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523748328 |
ALG6
|
Health Risk |
Pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523748367 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523748412 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523748430 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523749799 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2523750197 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523750276 |
CAMTA1
|
Health Risk |
Pathogenic |
Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Cerebellar dysfunction with variable cognitive and behavioral abnormalities |
| RS2523750296 |
ALG6
|
Health Risk |
Pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523750373 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS2523750391 |
ALG6
|
Health Risk |
Pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523750476 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523750633 |
ALG6
|
Health Risk |
Pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523751567 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2523751766 |
ABCA4
|
Health Risk |
Pathogenic |
Severe early-childhood-onset retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS2523751784 |
CAMTA1
|
Health Risk |
Likely pathogenic |
Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Cerebellar dysfunction with variable cognitive and behavioral abnormalities |
| RS2523752501 |
ABCA4
|
Health Risk |
Pathogenic |
Stargardt disease, Stargardt disease |
| RS2523755663 |
ALG6
|
Health Risk |
Pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523755672 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523755782 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523756100 |
CAMTA1
|
Health Risk |
Pathogenic |
— |
| RS2523757441 |
CAMTA1
|
Health Risk |
Pathogenic |
— |
| RS2523760441 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2523760594 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2523760621 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523760673 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523760827 |
ALG6
|
Health Risk |
Pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523765294 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS2523765410 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy, Cone-rod dystrophy |
| RS2523768305 |
ALG6
|
Health Risk |
Pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523768344 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523768354 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523768384 |
ALG6
|
Health Risk |
Pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523768434 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523768622 |
DOCK7
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS2523770658 |
DOCK7
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 23 |
| RS2523771313 |
ABCA4
|
Health Risk |
Pathogenic |
Severe early-childhood-onset retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS2523771540 |
ABCA4
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 19, Retinitis pigmentosa 19 |
| RS2523771792 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS2523771800 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS2523773776 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS2523774251 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2523774434 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2523778270 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2523780097 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2523780315 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS2523780335 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2523780433 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS2523788919 |
PGM1
|
Health Risk |
Pathogenic |
PGM1-congenital disorder of glycosylation, PGM1-congenital disorder of glycosylation |
| RS2523790513 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2523790517 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS2523791093 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2523791122 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2523791418 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2523793326 |
ALG6
|
Health Risk |
Pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523793339 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523794331 |
ALG6
|
Health Risk |
Pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523794684 |
ALG6
|
Health Risk |
Pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2523797555 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2523797636 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2523797746 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS2523797840 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2523798097 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2523798563 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2523798740 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2523798798 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2523805141 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS2523805441 |
ABCA4
|
Health Risk |
Pathogenic |
— |